Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005465 220002137 1.77 0 Disease modification (D) 2013-12-21 2013-12-21 Trial Unspecified Y N 220028245 TRIAL
220005466 220002137 1.55 78.5 Not known (9) null 2013-01-11 AML17 TRIAL N null 220028245 AML17 TRIAL
220005467 220002138 1.79 null null 2017-05-07 2017-05-07 AML17 TRIAL 01 N 220028248 AML17 TRIAL
220005468 220002138 null 103.8 Curative (C) null 2017-03-25 AML17 TRIAL null null 220028248 AML17 TRIAL
220005469 220002139 1.84 null null null 2016-08-03 Cytarabine Low Dose 2 null 220028256 CYTARABINE
220005470 220002140 1.7 60.2 Curative (C) 2016-08-12 2016-08-12 AML17 TRIAL Y N 220028257 AML17 TRIAL
220005471 220011161 1.78 null Curative (C) 2015-04-14 2015-04-15 Cytarabine low (10to20mg/m2) IV/SC 02 N 220028258 CYTARABINE
220005472 220011161 null 58.4 Curative (C) 2017-05-12 2017-05-12 AML17 TRIAL null N 220028258 AML17 TRIAL
220005473 220002141 null null Disease modification (D) 2015-03-20 2015-03-20 CYTARABINE N N 220028261 CYTARABINE
220005474 220002142 null 56.3 Curative (C) 2013-03-06 2013-03-06 AML17 TRIAL 1 N 220028266 AML17 TRIAL
220005475 220002142 1.63 51.2 Not known (9) 2014-11-16 2014-11-21 Trial Unspecified Y N 220028266 TRIAL
220005479 220002144 0 null null 2017-11-25 2017-11-26 AML17 TRIAL Y null 220028272 AML17 TRIAL
220005480 220011164 1.6 70.4 Disease modification (D) 2015-02-05 2015-02-05 Trial Unspecified Y N 220028273 TRIAL
220005481 220011164 0 80.7 Palliative (P) 2014-06-24 2014-06-26 Cytarabine Low Dose 99 N 220028273 CYTARABINE
220005482 220011164 null 65.9 Curative (C) 2013-01-31 2013-02-01 AML17 TRIAL null N 220028273 AML17 TRIAL
220005483 220002145 1.68 74.7 Curative (C) 2013-05-20 2013-05-21 AML17 TRIAL Y null 220028281 AML17 TRIAL
220005484 220011165 1.59 72.3 Palliative (P) 2016-12-04 2016-12-06 Trial Unspecified Y N 220028284 TRIAL
220005485 220002146 1.7 56.3 Not known (9) 2016-09-12 2016-09-16 AML17 TRIAL Y N 220028290 AML17 TRIAL
220005486 220002146 1.78 57.2 Curative (C) null 2017-03-17 AML17 TRIAL null null 220028290 AML17 TRIAL
220005487 220002146 1.73 66.9 null 2016-08-12 2016-08-19 Trial Unspecified N N 220028290 TRIAL
220005488 220002147 1.72 0 Palliative (P) 2016-12-06 2016-12-06 Cytarabine Low Dose 02 null 220028302 CYTARABINE
220005489 220002148 1.55 147.9 Palliative (P) null 2017-07-10 Cytarabine Low Dose N N 220028303 CYTARABINE
220005490 220011167 1.83 83 Curative (C) 2017-01-14 2017-01-16 LI-1 TRIAL Y N 220028304 TRIAL
220005491 220011167 1.69 88.6 Curative (C) 2014-11-15 2014-11-17 Trial Unspecified Y N 220028304 TRIAL
220005492 220002149 null null Disease modification (D) 2015-09-19 2015-10-02 Cytarabine low (10to20mg/m2) IV/SC N N 220028309 CYTARABINE
220005493 220011168 0 71 Palliative (P) 2017-10-19 2017-10-19 CYTARABINE N N 220028311 CYTARABINE
220005494 220002150 1.6 64.4 Curative (C) 2013-08-14 2013-08-14 Trial Unspecified 01 N 220028324 TRIAL
220005495 220002150 1.62 null Palliative (P) null 2016-08-09 Cytarabine Low Dose null null 220028324 CYTARABINE
220005496 220002150 null 89.6 Palliative (P) 2014-03-25 2014-03-25 Trial Unspecified 1 N 220028324 TRIAL
220005497 220002151 1.74 74 Curative (C) 2014-10-28 2014-11-04 Cytarabine Low Dose 2 N 220028329 CYTARABINE
220005498 220002152 1.61 null null 2013-02-27 2013-02-28 Cytarabine Low Dose 02 N 220028330 CYTARABINE
220005499 220002153 1.7 null Disease modification (D) 2013-09-13 2013-09-13 Cytarabine Low Dose null null 220028331 CYTARABINE
220005500 220002153 1.78 105 Curative (C) null 2013-04-12 Cytarabine Low Dose null null 220028331 CYTARABINE
220005501 220002153 1.73 null Curative (C) null 2017-09-10 Trial Unspecified null null 220028331 TRIAL
220005502 220021221 1.71 74.5 Curative (C) 2015-03-24 2015-03-27 Trial Unspecified Y null 220028338 TRIAL
220005503 220021713 null null Curative (C) 2015-07-13 2015-07-13 Cytarabine Low Dose N N 220028339 CYTARABINE
220005504 220021713 1.73 84.2 Curative (C) null 2013-04-25 AML17 TRIAL null null 220028339 AML17 TRIAL
220005510 220002155 1.66 77.2 Curative (C) 2014-06-12 2014-06-19 AML17 TRIAL 01 N 220028355 AML17 TRIAL
220005511 220002155 1.71 null Palliative (P) 2013-06-28 2013-08-08 Cytarabine Low Dose Y N 220028355 CYTARABINE
220005514 220002156 null null Palliative (P) 2016-03-06 2016-03-06 Trial Unspecified Y N 220028364 TRIAL
220005515 220011173 null 119.8 Curative (C) 2016-12-05 2016-12-05 AML17 TRIAL 1 N 220028367 AML17 TRIAL
220005516 220002157 1.74 null Palliative (P) 2015-02-07 2015-02-08 Cytarabine low (10to20mg/m2) IV/SC null N 220028369 CYTARABINE
220005517 220002157 1.5 111 Curative (C) 2014-11-02 2014-11-06 AML17 TRIAL 01 N 220028369 AML17 TRIAL
220005518 220002158 null 135 null 2015-04-15 2015-04-20 AML17 TRIAL null null 220028374 AML17 TRIAL
220005519 220011175 1.75 null Palliative (P) 2015-02-14 2015-02-14 CYTARABINE N N 220028376 CYTARABINE
220005520 220002159 null 81.4 Not known (9) 2013-08-18 2013-08-19 LI-1 TRIAL null null 220028378 TRIAL
220005521 220002159 0 41.9 Palliative (P) 2016-11-23 2016-11-23 Trial Unspecified Y N 220028378 TRIAL
220005522 220015984 1.53 80 Curative (C) 2017-07-21 2017-08-04 AML17 TRIAL null N 220028384 AML17 TRIAL
220005523 220002160 1.74 65.9 Curative (C) 2017-11-07 2017-11-14 AML17 TRIAL Y null 220028388 AML17 TRIAL
220005524 220002160 1.77 91 Curative (C) 2014-09-03 2014-09-03 Trial Unspecified 01 N 220028388 TRIAL